Highly protective antimalarial antibodies via precision library generation and yeast display screening
<jats:p>The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturatio...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Rockefeller University Press
2022
|
Online Access: | https://hdl.handle.net/1721.1/145918 |